Dr. Andrew Huff

Yeah.

Simply that Gana function technology is used for virology and vaccine development.

And mRNA is a huge portfolio of new vaccine technology development.

Thank you.

Okay.

That's the answer.

And there's, the funny thing is if you look at,

mRNA technology and its future.

A lot of corporations have banked in the pharmaceutical or biotech industry on mRNA being the future vaccine technology.

And I think if you look at the rise in cancers associated with mRNA technology and the SARS-CoV-2 vaccine, and there's a new study, a recent study that came out in Korea, which is a massive cohort study with a large, has a lot of statistical power, found five or six cancers that were

associated with the vaccine.

Okay.

And then many of these other studies looked at one type of cancer, for example, lymphoma in Sweden, they didn't find an association, but this Korean study looked at all types of cancers and they're now finding these associations.

So the writing's on the wall for mRNA technology.

I don't, do not think that it's going to be the future vaccine technology.

And frankly, I'm not so concerned anymore with the old way of thinking about

that the emerging infectious disease threat that we should be concerned about are old world diseases.

So bacillus anthracis being weaponized, for example, a coronavirus being weaponized.

Gain-of-function technology has evolved within the last decade

two to three years at such a rapid pace, the future threat we need to be mitigating against and protecting against is actually synthetic pathogens and synthetic life.